Platelets and von Willebrand factor in atherogenesis.
暂无分享,去创建一个
[1] B. Kaufmann,et al. Von Willebrand Factor Interacts with Surface-Bound C1q and Induces Platelet Rolling , 2016, The Journal of Immunology.
[2] O. Franco,et al. Von Willebrand Factor, ADAMTS13, and the Risk of Mortality: The Rotterdam Study , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[3] L. Uhlmann,et al. Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis , 2016, Drug design, development and therapy.
[4] P. Libby,et al. Inflammation and thrombosis – testing the hypothesis with anti- inflammatory drug trials , 2016, Thrombosis and Haemostasis.
[5] O. Franco,et al. Low ADAMTS‐13 activity and the risk of coronary heart disease – a prospective cohort study: the Rotterdam Study , 2016, Journal of thrombosis and haemostasis : JTH.
[6] M. Schattner,et al. Platelets: New Bricks in the Building of Neutrophil Extracellular Traps , 2016, Front. Immunol..
[7] C. Ballantyne,et al. Defective Association of the Platelet Glycoprotein Ib–IX Complex with the Glycosphingolipid-Enriched Membrane Domain Inhibits Murine Thrombus and Atheroma Formation , 2016, The Journal of Immunology.
[8] F. Peyvandi,et al. Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. , 2016, The New England journal of medicine.
[9] Yan-Wei Hu,et al. Possible roles of platelet-derived microparticles in atherosclerosis. , 2016, Atherosclerosis.
[10] Junmei Chen,et al. High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion. , 2016, Blood.
[11] L. Badimón,et al. High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis , 2015, Thrombosis and Haemostasis.
[12] P. Metharom,et al. Thrombin-induced reactive oxygen species generation in platelets: A novel role for protease-activated receptor 4 and GPIbα , 2015, Redox biology.
[13] H. Jo,et al. Flow-dependent expression of ectonucleotide tri(di)phosphohydrolase-1 and suppression of atherosclerosis. , 2015, The Journal of clinical investigation.
[14] Ying Zheng,et al. Flow-driven assembly of VWF fibres and webs in in vitro microvessels , 2015, Nature Communications.
[15] J. Lindner,et al. Molecular Imaging of Platelet–Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis , 2015, Circulation. Cardiovascular imaging.
[16] C. Bruehl,et al. Mechanism and functional impact of CD40 ligand-induced von Willebrand factor release from endothelial cells , 2015, Thrombosis and Haemostasis.
[17] Junmei Chen,et al. Hypochlorous Acid Generated by Neutrophils Inactivates ADAMTS13 , 2014, The Journal of Biological Chemistry.
[18] J. Deckers,et al. 'Corrigendum to "Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients" [Atherosclerosis 207 (2009) 250-4]' , 2014 .
[19] P. von Hundelshausen,et al. Platelets and their chemokines in atherosclerosis—clinical applications , 2014, Front. Physiol..
[20] K. Ley,et al. Genetic deletion of platelet glycoprotein Ib alpha but not its extracellular domain protects from atherosclerosis , 2014, Thrombosis and Haemostasis.
[21] S. Israels,et al. Markers of Platelet Activation Are Increased in Adolescents With Type 2 Diabetes , 2014, Diabetes Care.
[22] A. Chauhan,et al. ADAMTS13 modulates atherosclerotic plaque progression in mice via a VWF‐dependent mechanism , 2014, Journal of thrombosis and haemostasis : JTH.
[23] J. Cho. Protein disulfide isomerase in thrombosis and vascular inflammation , 2013, Journal of thrombosis and haemostasis : JTH.
[24] A. Weyrich,et al. Platelets as cellular effectors of inflammation in vascular diseases. , 2013, Circulation research.
[25] S. D. De Meyer,et al. Unwinding the von Willebrand factor strings puzzle. , 2013, Blood.
[26] O. McCarty,et al. Molecular Imaging of Inflammation and Platelet Adhesion in Advanced Atherosclerosis Effects of Antioxidant Therapy With NADPH Oxidase Inhibition , 2013, Circulation. Cardiovascular imaging.
[27] D. Rader,et al. Genetic Ablation of Adamts13 Gene Dramatically Accelerates the Formation of Early Atherosclerosis in a Murine Model , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[28] D. Bonatto,et al. Protein Disulfide Isomerase Is Required for Platelet-derived Growth Factor-induced Vascular Smooth Muscle Cell Migration, Nox1 NADPH Oxidase Expression, and RhoGTPase Activation , 2012, The Journal of Biological Chemistry.
[29] S. Basili,et al. Immediate Antioxidant and Antiplatelet Effect of Atorvastatin via Inhibition of Nox2 , 2012, Circulation.
[30] A. Chauhan,et al. ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice. , 2012, Blood.
[31] P. Gresele,et al. Inhibitors of the interaction between von Willebrand factor and platelet GPIb/IX/V. , 2012, Handbook of experimental pharmacology.
[32] J. Italiano,et al. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. , 2011, Blood.
[33] H. Deckmyn,et al. The CX3C chemokine fractalkine mediates platelet adhesion via the von Willebrand receptor glycoprotein Ib. , 2011, Blood.
[34] K. Ravid,et al. Adenosine and blood platelets , 2011, Purinergic Signalling.
[35] D. Scholtens,et al. The Hemostatic System as a Modulator of Atherosclerosis , 2011 .
[36] P. Mannucci. Platelet/von Willebrand factor inhibitors to the rescue of ischemic stroke. , 2010, Arteriosclerosis, Thrombosis and Vascular Biology.
[37] O. McCarty,et al. Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotype. , 2010, JACC. Cardiovascular imaging.
[38] Junmei Chen,et al. Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13. , 2010, Blood.
[39] C. Gachet,et al. Studies of mice lacking the GPIb‐V‐IX complex question the role of this receptor in atherosclerosis , 2009, Journal of thrombosis and haemostasis : JTH.
[40] P. Hordijk,et al. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases , 2009, Journal of leukocyte biology.
[41] C. Gleissner,et al. Platelet Chemokines in Vascular Disease , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[42] Jizhong Lou,et al. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. , 2008, The Journal of clinical investigation.
[43] P. Hordijk,et al. Transendothelial migration drives dissociation of plateletmonocyte complexes , 2008, Thrombosis and Haemostasis.
[44] X. Zheng,et al. Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells , 2008, Journal of thrombosis and haemostasis : JTH.
[45] B. Jilma,et al. Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes , 2008, Circulation.
[46] M. Gawaz,et al. Platelet-vessel Wall Interactions in Atherosclerotic Disease Theme Issue Article Platelet Secretion Andgeneration of Cytokines , 2022 .
[47] N. Caplice,et al. Plaque neovascularization and antiangiogenic therapy for atherosclerosis. , 2007, Journal of the American College of Cardiology.
[48] A. Chauhan,et al. Formation of platelet strings and microthrombi in the presence of ADAMTS‐13 inhibitor does not require P‐selectin or β3 integrin , 2007, Journal of thrombosis and haemostasis : JTH.
[49] W. Siess,et al. Glycoprotein Ibα inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques , 2007, Thrombosis and Haemostasis.
[50] Z. Ruggeri,et al. The role of von Willebrand factor in thrombus formation. , 2007, Thrombosis research.
[51] J. Akkerman,et al. Platelet Activation by Low Density Lipoprotein and High Density Lipoprotein , 2006, Pathophysiology of Haemostasis and Thrombosis.
[52] T. Ohmori,et al. Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. , 2006, Blood.
[53] M. Gawaz,et al. Platelets in inflammation and atherogenesis. , 2005, The Journal of clinical investigation.
[54] J. Loscalzo,et al. Endogenous Mechanisms of Inhibition of Platelet Function , 2005, Microcirculation.
[55] O. McCarty,et al. Preferential binding of platelets to monocytes over neutrophils under flow. , 2005, Biochemical and biophysical research communications.
[56] C. Weber. Platelets and chemokines in atherosclerosis: partners in crime. , 2005, Circulation research.
[57] D. Lane,et al. Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. , 2005, Blood.
[58] B. Jilma,et al. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation , 2005, Thrombosis and Haemostasis.
[59] P. Ganz,et al. Role of Endothelial Dysfunction in Atherosclerosis , 2004, Circulation.
[60] S. Nagueh,et al. Avoiding Papillary Muscle Infarction With Myocardial Contrast Echocardiographic Guidance of Nonsurgical Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy , 2004 .
[61] K. Ley,et al. Role of platelets in the development of atherosclerosis. , 2004, Trends in cardiovascular medicine.
[62] Z. Ruggeri,et al. Von Willebrand factor, platelets and endothelial cell interactions , 2003, Journal of thrombosis and haemostasis : JTH.
[63] Andreas Schober,et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E , 2003, Nature Medicine.
[64] Andrew S. Holmes,et al. Platelets and Cardiovascular Disease , 2002, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.
[65] Kazuo Fujikawa,et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. , 2002, Blood.
[66] Zaverio M. Ruggeri,et al. Platelets in atherothrombosis , 2002, Nature Medicine.
[67] M. Gawaz,et al. A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation , 2002, The Journal of experimental medicine.
[68] K. Ley,et al. Deposition of Platelet RANTES Triggering Monocyte Recruitment Requires P-Selectin and Is Involved in Neointima Formation After Arterial Injury , 2002, Circulation.
[69] A. Zeiher,et al. CD40 Ligand Inhibits Endothelial Cell Migration by Increasing Production of Endothelial Reactive Oxygen Species , 2002, Circulation.
[70] Volker Klauss,et al. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. , 2002, Blood.
[71] J. Vermylen,et al. atherosclerosis-prone sites in response to hypercholesterolemia Endothelial von Willebrand factor recruits platelets to , 2013 .
[72] K. Hirata,et al. Involvement of NADH/NADPH oxidase in human platelet ROS production. , 2001, Thrombosis research.
[73] C. Esmon,et al. Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis. , 2001, The American journal of pathology.
[74] D. Wagner,et al. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. , 2001, Blood.
[75] K. Ley,et al. RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium , 2001, Circulation.
[76] Renu Virmani,et al. Healed Plaque Ruptures and Sudden Coronary Death: Evidence That Subclinical Rupture Has a Role in Plaque Progression , 2001, Circulation.
[77] R. Gryglewski,et al. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation. , 2001, Medical science monitor : international medical journal of experimental and clinical research.
[78] R. Hynes,et al. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. , 2000, Blood.
[79] R. Kroczek,et al. Activated Platelets Induce Tissue Factor Expression on Human Umbilical Vein Endothelial Cells by Ligation of CD40 , 1998, Thrombosis and Haemostasis.
[80] L. Koenderman,et al. P‐selectin and MAC‐1 mediate monocyte rolling and adhesion to ECM‐bound platelets under flow conditions , 1998, Journal of leukocyte biology.
[81] P. Libby,et al. Reduction of atherosclerosis in mice by inhibition of CD40 signalling , 1998, Nature.
[82] Reinhold Förster,et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells , 1998, Nature.
[83] W. Haefeli,et al. Acute von Willebrand Factor Secretion from the Endothelium In Vivo: Assessment through Plasma Propeptide (vWf:AgII) Levels , 1997, Thrombosis and Haemostasis.
[84] C. Wollheim,et al. Reactive oxygen intermediates induce regulated secretion of von Willebrand factor from cultured human vascular endothelial cells. , 1995, Blood.
[85] A. Hamsten,et al. Increased platelet-derived mitogenic activity in plasma of young patients with coronary atherosclerosis. , 1986, Atherosclerosis.